Literature DB >> 21344323

Estimating measures of interaction on an additive scale for preventive exposures.

Mirjam J Knol1, Tyler J VanderWeele, Rolf H H Groenwold, Olaf H Klungel, Maroeska M Rovers, Diederick E Grobbee.   

Abstract

Measures of interaction on an additive scale (relative excess risk due to interaction [RERI], attributable proportion [AP], synergy index [S]), were developed for risk factors rather than preventive factors. It has been suggested that preventive factors should be recoded to risk factors before calculating these measures. We aimed to show that these measures are problematic with preventive factors prior to recoding, and to clarify the recoding method to be used to circumvent these problems. Recoding of preventive factors should be done such that the stratum with the lowest risk becomes the reference category when both factors are considered jointly (rather than one at a time). We used data from a case-control study on the interaction between ACE inhibitors and the ACE gene on incident diabetes. Use of ACE inhibitors was a preventive factor and DD ACE genotype was a risk factor. Before recoding, the RERI, AP and S showed inconsistent results (RERI = 0.26 [95%CI: -0.30; 0.82], AP = 0.30 [95%CI: -0.28; 0.88], S = 0.35 [95%CI: 0.02; 7.38]), with the first two measures suggesting positive interaction and the third negative interaction. After recoding the use of ACE inhibitors, they showed consistent results (RERI = -0.37 [95%CI: -1.23; 0.49], AP = -0.29 [95%CI: -0.98; 0.40], S = 0.43 [95%CI: 0.07; 2.60]), all indicating negative interaction. Preventive factors should not be used to calculate measures of interaction on an additive scale without recoding.

Entities:  

Mesh:

Year:  2011        PMID: 21344323      PMCID: PMC3115067          DOI: 10.1007/s10654-011-9554-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  Confidence interval estimation of interaction.

Authors:  D W Hosmer; S Lemeshow
Journal:  Epidemiology       Date:  1992-09       Impact factor: 4.822

2.  Calculating measures of biological interaction.

Authors:  Tomas Andersson; Lars Alfredsson; Henrik Källberg; Slobodan Zdravkovic; Anders Ahlbom
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  The identification of synergism in the sufficient-component-cause framework.

Authors:  Tyler J VanderWeele; James M Robins
Journal:  Epidemiology       Date:  2007-05       Impact factor: 4.822

4.  Estimation of the relative excess risk due to interaction and associated confidence bounds.

Authors:  David B Richardson; Jay S Kaufman
Journal:  Am J Epidemiol       Date:  2009-02-11       Impact factor: 4.897

5.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

6.  How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology.

Authors:  J Hallqvist; A Ahlbom; F Diderichsen; C Reuterwall
Journal:  J Intern Med       Date:  1996-05       Impact factor: 8.989

7.  Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.

Authors:  O Bozkurt; W M M Verschuren; B M A van Wieren-de Wijer; M J Knol; A de Boer; D E Grobbee; M I Geerlings; E R Heerdink; O H Klungel
Journal:  J Hum Hypertens       Date:  2008-06-19       Impact factor: 3.012

8.  White blood cell count and renin-angiotensin system inhibitors for the risk of cancer in type 2 diabetes.

Authors:  Xilin Yang; Ronald C W Ma; Wing Yee So; Gary T C Ko; Alice P S Kong; Hailu Zhao; Gang Xu; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes Res Clin Pract       Date:  2009-11-22       Impact factor: 5.602

9.  Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?

Authors:  Stein Hallan; Renée de Mutsert; Sven Carlsen; Friedo W Dekker; Knut Aasarød; Jostein Holmen
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

10.  An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma.

Authors:  Ingo Marenholz; Tamara Kerscher; Anja Bauerfeind; Jorge Esparza-Gordillo; Renate Nickel; Thomas Keil; Susanne Lau; Klaus Rohde; Ulrich Wahn; Young-Ae Lee
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

View more
  184 in total

1.  Recommendations for presenting analyses of effect modification and interaction.

Authors:  Mirjam J Knol; Tyler J VanderWeele
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  Does health insurance mitigate inequities in non-communicable disease treatment? Evidence from 48 low- and middle-income countries.

Authors:  Abdulrahman M El-Sayed; Anton Palma; Lynn P Freedman; Margaret E Kruk
Journal:  Health Policy       Date:  2015-07-29       Impact factor: 2.980

3.  Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.

Authors:  Iris Y Kim; Éilis J O'Reilly; Katherine C Hughes; Xiang Gao; Michael A Schwarzschild; Marjorie L McCullough; Marian T Hannan; Rebecca A Betensky; Alberto Ascherio
Journal:  Mov Disord       Date:  2018-01-10       Impact factor: 10.338

4.  Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report.

Authors:  Carolyn M Hutter; Leah E Mechanic; Nilanjan Chatterjee; Peter Kraft; Elizabeth M Gillanders
Journal:  Genet Epidemiol       Date:  2013-10-05       Impact factor: 2.135

5.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

6.  Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population.

Authors:  Zi-Yi Jin; Ming Wu; Ren-Qiang Han; Xiao-Feng Zhang; Xu-Shan Wang; Ai-Ming Liu; Jin-Yi Zhou; Qing-Yi Lu; Zuo-Feng Zhang; Jin-Kou Zhao
Journal:  Cancer Prev Res (Phila)       Date:  2013-05-08

7.  Gender differences in psychosocial work factors, work-personal life interface, and well-being among Swedish managers and non-managers.

Authors:  Anna Nyberg; Constanze Leineweber; Linda Magnusson Hanson
Journal:  Int Arch Occup Environ Health       Date:  2015-03-12       Impact factor: 3.015

8.  Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

Authors:  Bríd M Ryan; Ana I Robles; Andrew C McClary; Majda Haznadar; Elise D Bowman; Sharon R Pine; Derek Brown; Mohammed Khan; Kouya Shiraishi; Takashi Kohno; Hirokazu Okayama; Ramakrishna Modali; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

9.  Maternal caffeine consumption and risk of congenital limb deficiencies.

Authors:  Lei Chen; Erin M Bell; Marilyn L Browne; Charlotte M Druschel; Paul A Romitti; Rebecca J Schmidt; Trudy L Burns; Roxana Moslehi; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18

10.  Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites.

Authors:  Kevin P Delaney; Jacqueline Rurangirwa; Shelley Facente; Teri Dowling; Mike Janson; Thomas Knoble; Annie Vu; Yunyin W Hu; Peter R Kerndt; Jan King; Susan Scheer
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.